These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3201308)

  • 1. Transcription medication error with transdermal clonidine.
    Mallet L; Cooper JW
    South Med J; 1988 Dec; 81(12):1597-8. PubMed ID: 3201308
    [No Abstract]   [Full Text] [Related]  

  • 2. Transdermal clonidine. Patching up errors.
    Cohen MR
    Nursing; 2003 Sep; 33(9):12. PubMed ID: 14562817
    [No Abstract]   [Full Text] [Related]  

  • 3. Transdermal clonidine: therapeutic considerations.
    Sica DA; Grubbs R
    J Clin Hypertens (Greenwich); 2005 Sep; 7(9):558-62. PubMed ID: 16227779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old wine into new bottles. A critical evaluation of transdermal clonidine in the treatment of hypertension.
    Mathias CJ
    Clin Auton Res; 1993 Dec; 3(6):355. PubMed ID: 8193520
    [No Abstract]   [Full Text] [Related]  

  • 5. Transdermal clonidine for the treatment of essential hypertension.
    McChesney JA; Ryan C; Shaw RE; Fishman-Rosen J; Murphy MC
    Compr Ther; 1987 Apr; 13(4):49-53. PubMed ID: 3568603
    [No Abstract]   [Full Text] [Related]  

  • 6. Transdermal antihypertensive for elderly hypertensives.
    Bhatia RS
    J Assoc Physicians India; 1993 May; 41(5):316. PubMed ID: 8300479
    [No Abstract]   [Full Text] [Related]  

  • 7. Transdermal clonidine as an adjunct to nifedipine-GITS therapy in patients with mild-to-moderate hypertension.
    Houston MC; Hays L
    Am Heart J; 1993 Oct; 126(4):918-23. PubMed ID: 8213450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral substitution in patients sensitized by transdermal clonidine treatment.
    Maibach HI
    Contact Dermatitis; 1987 Jan; 16(1):1-8. PubMed ID: 3816202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
    Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
    Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebound hypertension after discontinuation of transdermal clonidine.
    Schmidt GR; Schuna AA
    Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
    Hollifield J
    Am Heart J; 1986 Oct; 112(4):900-6. PubMed ID: 2945414
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension.
    Burris JF; Papademetriou V; Wallin JD; Cook ME; Weidler DJ
    Am J Med; 1991 Jul; 91(1A):22S-28S. PubMed ID: 1867225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma dilution during transdermal clonidine antihypertensive monotherapy.
    Zawada ET; Jensen RA; Williams L; Zeigler DW; Kauker ML
    Int J Artif Organs; 1989 Mar; 12(3):200-3. PubMed ID: 2744881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin reactions to long-term transdermal clonidine.
    Dick JB; Northridge DB; Lawson AA
    Lancet; 1987 Feb; 1(8531):516. PubMed ID: 2881081
    [No Abstract]   [Full Text] [Related]  

  • 19. New indices in the evaluation of clonidine transdermal therapy of hypertension.
    de Leonardis V; de Scalzi M; Becucci A; Lusini C; Cinelli P
    Int J Clin Pharmacol Res; 1989; 9(5):341-5. PubMed ID: 2625373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.